NIKE Bets on EMEA Growth: Can This Strategy Pay Off in FY26? — Positive
NKE Zacks Investment Research — August 13, 2025NKE's EMEA strategy drives growth by building on marketplace streamlining and boosting NIKE Digital through an integrated channel approach.
Novo Nordisk Rises 6% So Far in August: How to Play the Stock — Neutral
NVO Zacks Investment Research — August 13, 2025NVO stock climbs nearly 6% in August as Lilly's oral obesity candidate setback pivots investor sentiment toward the former's advancing pipeline.
Turkcell Iletişim Hizmetleri: Second Quarter 2025 Results — Neutral
TKC Business Wire — August 13, 2025ISTANBUL--(BUSINESS WIRE)--Turkcell Iletişim Hizmetleri (NYSE:TKC) (BIST:TCELL): Please note that all financial data is consolidated and comprises that of Turkcell Iletisim Hizmetleri A.S. (the “Company” or “Turkcell”) and its subsidiaries and associates (together referred to as the “Group”) unless otherwise stated. Our revenue segmentation was revised as of Q1 2025. Within this scope, all past data have been restated for comparability purposes. For a comprehensive explanation, please refer to.
Sun Country Airlines names D. Torque Zubeck as Senior Vice President and Chief Financial Officer — Neutral
SNCY GlobeNewsWire — August 13, 2025MINNEAPOLIS, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Sun Country Airlines (NASDAQ: SNCY) announced today that D. Torque Zubeck, formerly a managing director with Alaska Airlines, will join Sun Country as Senior Vice President and Chief Financial Officer on Tuesday, September 2.
EWM which focuses on 30 stocks from Malaysia is up by only low single-digits this year, and underperforming emerging markets and global markets quite significantly. We now feel EWM could witness better prospects ahead. Malaysia's macro outlook is stabilizing, with improved GDP growth, supportive government policies, and central bank rate cuts boosting domestic demand.
BiomX Inc. (NYSE:PHGE ) Q2 2025 Earnings Conference Call August 13, 2025 8:00 AM ET Company Participants Jonathan Eitan Solomon - CEO & Director Marina Wolfson - CFO & Secretary Conference Call Participants I-Eh Jen - Laidlaw & Company (UK) Ltd., Research Division Joseph Pantginis - H.C.
AN Supps Expands Innovation With Iconic Chiquita® Brand Collab and a Nationwide Walmart U.S. Launch — Neutral
WMT Business Wire — August 13, 2025NASHVILLE, Tenn.--(BUSINESS WIRE)--With the indulgence of beach barbeques and happy hours fading into rear view mirrors, consumers will stock up on health and wellness related foods and beverages, while shopping for the Fall. AN Supps, a division of Applied Nutrition PLC, has responded to this trend - joining forces with Chiquita® Brands International and thousands of Walmart U.S. stores to deliver protein and pre-workout sports beverage mixes. AN Supps began its partnership with Chiquita® earl.
HIMS 2-WEEK DEADLINE ALERT: HIMS Shares Decline Amid Lower Revenue Per Order For GLP-1 Following Novo Nordisk Collaboration Termination, Securities Class Action Pending -- Hagens Berman — Neutral
HIMS GlobeNewsWire — August 13, 2025SAN FRANCISCO, Aug. 13, 2025 (GLOBE NEWSWIRE) -- On August 5, 2025, investors in Hims & Hers Health (NYSE: HIMS) declined almost 11% in another sell-off after the company disclosed that it would lower revenue recognized per customer specific to its so-called personalized GLP-1 component, a medication the company compounds to treat weight loss. This disclosure comes as the company previously experienced a sell-off in its shares which triggered a securities class action lawsuit tied to a cancelled collaboration with pharmaceutical giant Novo Nordisk to expand the availability of one of two FDA-approved weight loss drugs -- Wegovy® -- to …
MKL Outperforms Industry, Trades at a Discount: How to Play the Stock — Positive
MKL Zacks Investment Research — August 13, 2025Markel Group is set to grow on rate increases, strategic buyouts, new business volume, solid capital position and prudent capital deployment.
Expectations for September Rate Cut Soar.
Large-Cap ETF (SPLG) Hits New 52-Week High — Positive
SPLG Zacks Investment Research — August 13, 2025SPLG surges to a 52-week high, lifted by record S&P 500 levels, rate-cut optimism, and AI-driven market momentum.
Crown Castle Stock Gains 16.3% in 6 Months: Will the Trend Continue? — Positive
CCI Zacks Investment Research — August 13, 2025CCI's 16.3% six-month climb is driven by 5G growth, tower expansion and stable revenues from long-term leases.
CRM Bets on ADAM Framework: Will it Fortify Leadership in Agentic AI? — Positive
CRM Zacks Investment Research — August 13, 2025Salesforce's ADAM framework, which includes Agents, Data, Apps, and Metadata, aims to power safe, scalable AI agents and fuel the company's next growth phase.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO — Neutral
MREO GlobeNewsWire — August 13, 2025NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Mereo BioPharma Group plc (“Mereo” or the “Company”) (NASDAQ: MREO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Milestone Scientific Schedules Second Quarter 2025 Financial Results and Business Update Conference Call — Neutral
MLSS GlobeNewsWire — August 13, 2025ROSELAND, N.J., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:00 AM Eastern Time on Friday, August 15th, 2025, to discuss the company's financial results for the second quarter ended June 30, 2025, as well as the company's corporate progress and other developments.
CoreWeave Tanks 15% Despite AI Growth Surge. Time to Back Up the Truck? — Neutral
CRWV 24/7 Wall Street — August 13, 2025Key Points in This Article: CoreWeave's (CRWV) Q2 revenue of $1.21 billion surpassed estimates, driven by AI demand.
AST SpaceMobile continues to miss satellite launch targets, delaying commercial service and raising doubts about execution. Competitive threats from Starlink and T-Mobile have intensified, making ASTS's late entry and value proposition less compelling. Revenue projections appear overly optimistic given persistent delays, questionable demand, and reliance on MNO partnerships for growth.
Mersana Therapeutics, Inc. (MRSN) Q2 2025 Earnings Call Transcript — Neutral
MRSN Seeking Alpha — August 13, 2025Mersana Therapeutics, Inc. (NASDAQ:MRSN ) Q2 2025 Earnings Conference Call August 13, 2025 8:00 AM ET Company Participants Brian C. DeSchuytner - Senior VP, CFO & COO Jason Fredette - Senior Vice President of Investor Relations & Corporate Communications Martin H.
Hudbay Minerals surges on $600M Mitsubishi investment in Copper World project — Positive
CPER HBM JJC Proactive Investors — August 13, 2025HudBay Minerals Inc. (TSX:HBM) shares surged after the miner announced a $600 million strategic investment from Mitsubishi for a 30% joint venture interest in the Copper World project in Arizona. Announced alongside its Q2 earnings, the deal includes an initial cash investment of $420 million, with $180 million to follow within 18 months.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - RARE — Neutral
RARE GlobeNewsWire — August 13, 2025NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or the “Company”) (NASDAQ: RARE). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.